维普中文期刊产品整合服务
49篇 您的检索式:作者名="Avery MA"
    题名 作者 年代 出处 被引量
1In vivo genome editing thrives with diversified CRISPR technologies显示文摘Prokaryotic type Ⅱ adaptive immune systems have been developed into the versatile CRISPR technology, which has been widely applied in sitespecific genome editing and has revolutionized biomedical research due to its superior efficiency and flexibility. Recent studies have greatly diversified CRISPR technologies by coupling it with various DNA repair mechanisms and targeting strategies.These new advances have significantly expanded the generation of genetically modified animal models, either by including species in which targeted genetic modification could not be achieved previously, or through introducing complex genetic modifications that take multiple steps and cost years to achieve using traditional methods. Herein, we review the recent developments and applications of CRISPR-based technology in generating various animal models, and discuss the everlasting impact of this new progress on biomedical research.Xun Ma Avery Sum-Yu Wong Hei-Yin Tam Samuel Yung-Kin Tsui Dittman Lai-Shun Chung Bo Feng 2018Zoological Research2018,39,2:2
2Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5^+ T follicular helper cells显示文摘Bryant VL Ma CS Avery DT 2007J Immunol2007,179,12:1
3Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy显示文摘Robert L. Avery Joel Pearlman Dante J. Pieramici Melvin D. Rabena Alessandro A. Castellarin Ma’an A. Nasir Matthew J. Giust Robert Wendel Arun Patel 2006Ophthalmology2006,,10:1
4A mild deprotection of trichloroethyl carbamates using indium metal 显示文摘Mineno T Choi SR Avery MA 2002Synlett2002,,6:1
5Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy 显示文摘Avery RL Pearlman J Pieramici DJ Rabena MD Castellarin AA Nasir MA 2006Ophtholrnology2006,113,10:1
6IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4显示文摘Avery D T Bryant V L Ma C S 0,,03:1
7IL-21 -induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4 显示文摘Avery DT Bryant VL Ma CS 2008J Immunol2008,181,3:1
8Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy显示文摘Robert L. Avery Joel Pearlman Dante J. Pieramici Melvin D. Rabena Alessandro A. Castellarin Ma’an A. Nasir Matthew J. Giust Robert Wendel Arun Patel 2006Ophthalmology2006,,10:1
9Cervico-isthmic corporeal pregnancy with delivery at term:a review of the literature with a case report显示文摘Avery DM Wells MA Harper DM 2009Obstet Gynecol Surv2009,64,5:1
10IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to en- hance their differentiation into plasmablasts显示文摘Berglund U Avery DT Ma CS 2013Blood2013,122,24:1
11IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4显示文摘Avery DT Bryant VL Ma CS 2008J Immunol2008,181,3:1
12Selective generation of functional somatically mutated lgM + CD27 +, but not Ig isotypeswitched, memory B cells in X-linked lymphoproliferative disease显示文摘Ma CS Pittaluga S Avery DT 2006J Clin Invest2006,116,2:1
13Early commitment ofna觙ve human CD4(+)T cells to the T follicular helper(T(FH))cell lineage is induced by IL-12显示文摘Ma CS Suryani S Avery DT 2009Immunol Cell Biol2009,87,8:1
14IL-21-induced isotypeswitching to IgG and IgA by human naive B cells isdifferentially regulated by IL-4显示文摘Avery DT Bryant VL Ma CS 2008J Immunol2008,181,3:1
15Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration显示文摘Avery RL Pieramici DJ Rabena MD Castellarin AA Nasir MA Giust MJ 2006Ophthalmology2006,113,3:1
16Improvement in drug-induced parkinsonism with electroconvulsive therapy显示文摘Baez MA Avery J 2011Am J Geriatr Pharma-cother2011,9,3:1
17Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells:predominant role of IL-21 produced by CXCR5+T follicular helper cells显示文摘BRYANT V L MA C S AVERY D T 2007J Immunol2007,179,12:1
18Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions显示文摘Dante J. Pieramici Melvin Rabena Alessandro A. Castellarin Ma'an Nasir Robert See Tamara Norton Andres Sanchez Sarah Risard Robert L. Avery 2008Ophthalmology2008,,10:1
19Intravitreal bevacizumab ( Avastin ) in the treatment of proliferative diabetic retinopathy显示文摘Avery RL Pearlman J Pieramici DJ Rabena MD Castellarin AA Nasir MA et a l 2006Ophthalmolo- gy2006,113,10:1
20Intravitreal bevacizumab (avastin) in the treatment of proliferative diabetic retinopathy显示文摘Avery RL Pearlman J Pieramici D J Rabena MD Castellarin AA Nasir MA 2006Ophthalmology2006,113,10:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费